Correlation Between Eliem Therapeutics and In8bio
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and In8bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and In8bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and In8bio Inc, you can compare the effects of market volatilities on Eliem Therapeutics and In8bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of In8bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and In8bio.
Diversification Opportunities for Eliem Therapeutics and In8bio
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between Eliem and In8bio is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and In8bio Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on In8bio Inc and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with In8bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of In8bio Inc has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and In8bio go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and In8bio
Given the investment horizon of 90 days Eliem Therapeutics is expected to under-perform the In8bio. But the stock apears to be less risky and, when comparing its historical volatility, Eliem Therapeutics is 1.42 times less risky than In8bio. The stock trades about -0.29 of its potential returns per unit of risk. The In8bio Inc is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 30.00 in In8bio Inc on August 29, 2024 and sell it today you would earn a total of 1.00 from holding In8bio Inc or generate 3.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 90.91% |
| Values | Daily Returns |
Eliem Therapeutics vs. In8bio Inc
Performance |
| Timeline |
| Eliem Therapeutics |
| In8bio Inc |
Eliem Therapeutics and In8bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and In8bio
The main advantage of trading using opposite Eliem Therapeutics and In8bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, In8bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in In8bio will offset losses from the drop in In8bio's long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| In8bio vs. Reviva Pharmaceuticals Holdings | In8bio vs. Cue Biopharma | In8bio vs. Lantern Pharma | In8bio vs. Anixa Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |